PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:27 AM ET

Sponsor Check › Person

DE
No photo found yet (own website and image search run after this page is viewed)

Douglas Eckert

Named as an officer, director or promoter on SEC Form D filings · NC · Aug 18, 2009 → Jun 8, 2015

2deals (issuers)
$52.8Mreported sold
128investors
11Form D filings
2009–2015years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Douglas Eckert is listed as an executive officer and director on 11 SEC Form D filings by 2 issuers between Aug 2009 and Jun 2015: Sprout Pharmaceuticals, Inc. (Raleigh, NC — pharmaceuticals — 2012–2015; $50M reported sold to 88 investors) and Slate Pharmaceuticals, Inc. (Durham, NC — pharmaceuticals — 2009–2010; $2.79M reported sold to 40 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $52.8M sold in total.

Listed alongside Anthony Wild (11 shared filings), Michael Ford (11 shared filings), Richard DeSchutter (11 shared filings), Robert S. Whitehead (11 shared filings), Trygve Mikkelsen (11 shared filings) and 13 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Douglas. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 11 public filings for Douglas Eckert and found 5 differences: Form D filed 17 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Douglas Eckert has not run yet — it is joining a line of 16,552 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Douglas Eckert..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

5 cases: 5 closed (disposition not in docket feed)

Douglas J. Eckert and Wendy L. Eckert closed
United States Bankruptcy Court, D. Minnesota · No. 09-43132 · Filed May 16, 2009 · Closed Sep 4, 2009
Role of Douglas J. Eckert and Wendy L. Eckert: Debtor · Outcome: Case closed 2009-09-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 10 federal dockets); court in MN (not a filing state)
Douglas S Eckert closed
United States Bankruptcy Court, M.D. Pennsylvania · No. 5:06-bk-50883 · Filed Jun 7, 2006 · Closed Oct 20, 2006
Role of Douglas S Eckert: Debtor · Outcome: Case closed 2006-10-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 10 federal dockets); court in PA (not a filing state)
Douglas S. Eckert closed
United States Bankruptcy Court, W.D. Arkansas · No. 5:02-bk-73963 · Filed Jun 25, 2002 · Closed Nov 21, 2003
Role of Douglas S. Eckert: Debtor · Outcome: Case closed 2003-11-21 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 10 federal dockets); court in AR (not a filing state)
Douglas Eckert and Grace Eckert closed
United States Bankruptcy Court, N.D. Georgia · No. 97-82626 · Filed Dec 22, 1997 · Closed Apr 26, 2002
Role of Douglas Eckert and Grace Eckert: Debtor · Outcome: Case closed 2002-04-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 10 federal dockets); court in GA (not a filing state)
DOUGLAS R. ECKERT closed
United States Bankruptcy Court, D. Arizona · No. 0:93-bk-00130 · Filed May 14, 1993 · Closed Oct 16, 2001
Role of DOUGLAS R. ECKERT: Debtor · Outcome: Case closed 2001-10-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 10 federal dockets); court in AR (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

5 differences found between the filings for Douglas Eckert (compared 11 filings on Oct 24, 2026)

Note · May 22, 2015 – Jun 8, 2015

Form D filed 17 days after the first sale — Sprout Pharmaceuticals, Inc.

The filing says the first sale was May 22, 2015. The Form D was filed Jun 8, 2015 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jun 8, 2015 ↗Sprout Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 30, 2014 – Jul 11, 2014

No amendment in the last 12 months on an offering that may still be open — Sprout Pharmaceuticals, Inc. (latest filing Jul 11, 2014)

The latest filing for this offering is dated Jul 11, 2014 (first sale Jun 30, 2014). It reports $4,303,856 sold of $15,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Jul 11, 2014 ↗Sprout Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 11, 2013 – Jul 26, 2013

No amendment in the last 12 months on an offering that may still be open — Sprout Pharmaceuticals, Inc. (latest filing Jul 26, 2013)

The latest filing for this offering is dated Jul 26, 2013 (first sale Jun 11, 2013). It reports $9,999,997 sold of $10,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Jul 26, 2013 ↗Sprout Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Sep 13, 2010 – Sep 27, 2010

No amendment in the last 12 months on an offering that may still be open — Slate Pharmaceuticals, Inc. (latest filing Sep 27, 2010)

The latest filing for this offering is dated Sep 27, 2010 (first sale Sep 13, 2010). It reports $1,990,000 sold of $2,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Sep 27, 2010 ↗Slate Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Aug 18, 2009 – Sep 27, 2010

Reported revenue range changed between filings — Slate Pharmaceuticals, Inc.

"Not Applicable" (Aug 18, 2009); then "Decline to Disclose" (Sep 27, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Aug 18, 2009 ↗Form D · Sep 27, 2010 ↗Slate Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 7 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $440,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 8, 2015 D
Sprout Pharmaceuticals, Inc.
File 021-241312
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Company's executive officers.
N/A no CRD number reportedEDGAR ↗
Jul 11, 2014 D
Sprout Pharmaceuticals, Inc.
File 021-220803
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Company's executive officers.
N/A no CRD number reportedEDGAR ↗
Jul 26, 2013 D/A
Sprout Pharmaceuticals, Inc.
File 021-198572
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Issuer's executive officers.
N/A no CRD number reportedEDGAR ↗
Jul 11, 2012 D/A
Sprout Pharmaceuticals, Inc.
File 021-180560
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Issuer's executive officers.
N/A no CRD number reportedEDGAR ↗
Mar 21, 2012 D
Sprout Pharmaceuticals, Inc.
File 021-175342
$0$0$0
The Proceeds will be used for working capital purposes, of which a portion will be used to pay the salaries of the Issuer's executive officers.
N/A no CRD number reportedEDGAR ↗
Sep 27, 2010 D
Slate Pharmaceuticals, Inc.
File 021-148195
$0$0$300,000 (est.)
The $300,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital.
N/A no CRD number reportedEDGAR ↗
Jan 29, 2010 D/A
Slate Pharmaceuticals, Inc.
File 021-133739
$0$0$140,000 (est.)
The $140,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital.
N/A no CRD number reportedEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Douglas Eckert on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

SP
Pharmaceuticals

Sprout Pharmaceuticals, Inc.

Raleigh, NC · Mar 21, 2012 → Jun 8, 2015 · 7 filings
  • Jun 8, 2015 · D · $50,000,008 sold of $50,000,008 · 5 investors · min. No minimum reported · role: Executive Officer, Director (Director, Secretary) EDGAR ↗
  • Jul 11, 2014 · D · $4,303,856 sold of $15,000,000 · 69 investors · min. $50,000 · role: Executive Officer, Director (Director and Secretary) EDGAR ↗
  • Jul 26, 2013 · D/A · $9,999,997 sold of $10,000,000 · 88 investors · min. $50,000 · role: Executive Officer, Director (Director and Secretary) EDGAR ↗
  • Jun 25, 2013 · D · $4,791,913 sold of $10,000,000 · 63 investors · min. $50,000 · role: Executive Officer, Director (Director and Secretary) EDGAR ↗
  • Jul 11, 2012 · D/A · $20,000,000 sold of $20,000,000 · 59 investors · min. $50,000 · role: Executive Officer, Director (Director and Secretary) EDGAR ↗
  • Jun 29, 2012 · D · $17,554,341 sold of $20,000,000 · 55 investors · min. $50,000 · role: Executive Officer, Director (Director and Secretary) EDGAR ↗
  • Mar 21, 2012 · D · $5,000,000 sold of $5,000,000 · 61 investors · min. $50,000 · role: Executive Officer, Director (Director and Secretary) EDGAR ↗

Raised $50M from 88 investors (100% of the $50M target) as of the latest filing. Douglas is listed as executive officer, director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Pharmaceuticals

Slate Pharmaceuticals, Inc.

Durham, NC · Aug 18, 2009 → Sep 27, 2010 · 4 filings
  • Sep 27, 2010 · D · $1,990,000 sold of $2,000,000 · 40 investors · min. $1 · role: Director EDGAR ↗
  • Jan 29, 2010 · D/A · $2,787,000 sold of $2,787,000 · 33 investors · min. $1 · role: Director EDGAR ↗
  • Nov 19, 2009 · D/A · $2,616,950 sold of $2,787,000 · 33 investors · min. $1 · role: Director EDGAR ↗
  • Aug 18, 2009 · D · $970,630 sold of $2,787,000 · 13 investors · min. $1 · role: Director EDGAR ↗

Raised $2.79M from 40 investors (100% of the $2M target) as of the latest filing. Douglas is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Douglas 18

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Ford

Director · 11 shared filings (2 issuers)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Richard DeSchutter

Director · 11 shared filings (2 issuers)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

RW
No photo found yet (own website and image search run after this page is viewed)
Person

Robert S. Whitehead

Executive Officer, Director · 11 shared filings (2 issuers) · also on 5 other issuers

Robert S. Whitehead is on 7 issuers in total — a repeat sponsor. Their page lists every one.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Trygve Mikkelsen

Director · 11 shared filings (2 issuers)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Wild

Director · 11 shared filings (2 issuers)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

BG
No photo found yet (own website and image search run after this page is viewed)
Person

Braxton Goodrich

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Petzold

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Cynthia Whitehead

Executive Officer, Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

WD
No photo found yet (own website and image search run after this page is viewed)
Person

W. Robert Dahl

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Symons

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

FP
No photo found yet (own website and image search run after this page is viewed)
Person

Fred Pruden

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

WD
No photo found yet (own website and image search run after this page is viewed)
Person

William Robert Dahl

Director · 4 shared filings (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

KC
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Ramsey Couch

Director · 2 shared filings (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Anne Tomalin

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

James Pruden

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Josephine Torrente

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Rich Franco

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Dahl

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Douglas Eckert. Their page shows their other deals.

The team behind the deals

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Douglas Eckert by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Douglas Eckert is listed on: none on file. No website or social profile named in Sprout Pharmaceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #302,891 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Raleigh, NC). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗North Carolina eCourts portal ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

North Carolina Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Douglas Eckert appears on a new Form D, or when a court case or SEC action is matched to them. See plans →